大连医科大学学报
大連醫科大學學報
대련의과대학학보
JOURNAL OF DALIAN MEDICAL UNIVERSITY
2014年
2期
168-170
,共3页
余晓龙%王嘉%曹斯佳%孙萍%张宇%蔡振刚%牟国煜
餘曉龍%王嘉%曹斯佳%孫萍%張宇%蔡振剛%牟國煜
여효룡%왕가%조사가%손평%장우%채진강%모국욱
男性乳腺癌%诊断%手术
男性乳腺癌%診斷%手術
남성유선암%진단%수술
male breast cancer%diagnosis%operation
目的:总结男性乳腺癌的外科诊治经验。方法收集2001年-2013年大连医科大学附属第一医院收治的16例男性乳腺癌患者的临床资料。病变位于左侧者7例,右侧者9例。16例患者均行手术治疗,11例患者行乳癌简化根治术,2例行单纯乳腺癌切除术,3例行乳腺癌标准根治术。结果术后病理诊断为浸润性导管癌13例,其余分别为腺癌、导管内癌、腺样囊性癌各1例。术后7例患者行辅助化疗,3例患者行辅助放疗。5年生存率为57.1%,10年生存率28.5%。结论以外科简化根治术为主,辅以化疗、放疗及内分泌的全身治疗是现阶段男性乳腺癌治疗的最佳模式。
目的:總結男性乳腺癌的外科診治經驗。方法收集2001年-2013年大連醫科大學附屬第一醫院收治的16例男性乳腺癌患者的臨床資料。病變位于左側者7例,右側者9例。16例患者均行手術治療,11例患者行乳癌簡化根治術,2例行單純乳腺癌切除術,3例行乳腺癌標準根治術。結果術後病理診斷為浸潤性導管癌13例,其餘分彆為腺癌、導管內癌、腺樣囊性癌各1例。術後7例患者行輔助化療,3例患者行輔助放療。5年生存率為57.1%,10年生存率28.5%。結論以外科簡化根治術為主,輔以化療、放療及內分泌的全身治療是現階段男性乳腺癌治療的最佳模式。
목적:총결남성유선암적외과진치경험。방법수집2001년-2013년대련의과대학부속제일의원수치적16례남성유선암환자적림상자료。병변위우좌측자7례,우측자9례。16례환자균행수술치료,11례환자행유암간화근치술,2례행단순유선암절제술,3례행유선암표준근치술。결과술후병리진단위침윤성도관암13례,기여분별위선암、도관내암、선양낭성암각1례。술후7례환자행보조화료,3례환자행보조방료。5년생존솔위57.1%,10년생존솔28.5%。결론이외과간화근치술위주,보이화료、방료급내분비적전신치료시현계단남성유선암치료적최가모식。
Objective To summarize the experience of surgical therapy for male breast cancer .Methods Clinical data of the 16 male breast cancer patients , who underwent surgical treatment in the 1st affiliated hospital of Dalian Medical Univer-sity during 2001-2013 , were retrospectively analyzed .All 16 patients received surgical treatment ,focus on left side in 7 cases and right side in 9 cases.Among them, modified radical mastectomy was conducted in 11, total mastectomy in 2, radical mastectomy in 3.Results Pathological dignosis shows that invasive ductal carcinoma in 13,adenocarcinoma and ductal carcinoma and cystadenocarcinoma in 1 case respectively after operation .7 cases received chemotherapy and 3 re-ceived radiotherapy .5 year survival rate is 57.1%and 10 year survival rate is 28.5%.Conclusion Modified radical mas-tectomy with adjuvant combination of chemoradiation therapy and endocrine therapy is the treatment mode for male breast cancer.